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To the Editor, 
 
We read with interest the article entitled “A pilot study assessing retinal pathology in psychosis 
using optical coherence tomography: Choroidal and macular thickness” recently published by Joe 
[1] et al. in your journal.  
In this pilot study the authors analyzed macular and choroidal thickness using spectral domain 
optical coherence tomography (SD-OCT) in patients with psychosis ( either schizophrenia or 
bipolar disorder) and found a significant thinning of macula and a non-significant decrease in 
choroidal thickness in the examined group in comparison with age-matched healthy subjects [1]. 
Although they should be congratulated for having studied first, to the best of our knowledge, 
choroidal thickness variations in patients with psychosis, we would like to point out some 
methodological concerns from an ophthalmological perspective. Firstly, the authors did not clarify 
if they performed the SD-OCT examination at the same time of the day both for the 6 patients with 
psychosis and for the control group. In this regard, several studies revealed that choroid is subjected 
to diurnal variations in its thickness, probably due to circadian hormonal changes modifying the 
blood supply of this tissue [2]. Thus, we deem that more information about the timing of the 
examination should have been provided for both the groups. 
Secondly, the authors did not specify if, beside reporting the ophthalmological medical history, they 
performed a complete ophthalmological examination including slit-lamp biomicroscopy , 
retinoscopy, tonometry measuring intraocular pressure (IOP) and, nonetheless, ocular biometry. In 
this regard, the Beijing Eye Study examined 3468 healthy subjects using SD-OCT and reported that 
choroidal thickness varied significantly in relation to ocular parameters such as a deep chamber, a 
thick lens and to axial lenght[3]. Moreover, also the refractive status of both the groups has not been 
reported; however, it is well know that even low myopic eyes (1 diopter or more) are characterized 
by a thinner choroid in comparison with emmetropic eyes [3]. Hence, the authors  should have 
provided more data on the ophthalmological examinations performed, in order to rule out possible 
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confounding factors when measuring retinal and choroid thickness. 
Thirdly, the authors did not report any information about the drugs given to psychotic patients; in 
this regard, typical antipsychotic drugs have been shown to be associated with uveal tract disorders 
and , nonetheless, it is known the positive association between phenothiazines and pigmentary 
retinopathy [4]. Thus, we deem that this could represent a limitation of the study, since the 
administration of antipsychotic drugs could have altered the findings in the study. 
Lastly, we agree with the authors’ statement considering the higher prevalence of diabetes in the 
psychotic group a possible confounding factor, because choroid has been proven to vary 
significantly in diabetic patients without clinical signs of retinopathy [5]. In conclusion, we think 
that these preliminary results should be confirmed in a larger sample of patients, not neglecting the 
importance of a correct screening and a complete eye examination in order to limit the possible 
confounding effect of the above-mentioned risk factors on retinal and choroidal thickness. 
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